Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?

Antonio Eduardo P Pesaro, Christopher B Granger, Renato D Lopes

Journal: American heart journal 2016;172():42-4

PMID: 26856214

Full Text on Elsevier Science View on PubMed

Abstract

Address: Hospital Albert Einstein Hospital, Sao Paulo, Brazil.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Federal University of Sao Paulo, Paulista School of Medicine, Sao Paulo, Brazil. Electronic address: [email protected].

DOI: 10.1016/j.ahj.2015.11.001

Link outs

Free resources

Medical:

https://medlineplus.gov/cholesterolmedicines.html

Other Literature Sources:

https://scite.ai/reports/26856214

Subscription / membership required

Full Text Sources:

MeSH Terms: Acute Coronary Syndrome, Anticholesteremic Agents, Brazil, Cholesterol, Dose-Response Relationship, Drug, Ezetimibe, Ezetimibe, Simvastatin Drug Combination, Humans, Incidence, Randomized Controlled Trials as Topic, Treatment Outcome